All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 22 November 20263 min read

Qualitek Labs (QLL) Q2 FY27 Profit Drops 30% on Heavy Expansion Costs

Qualitek Labs posted 33% YoY revenue growth in Q2 FY27, but a sharp rise in costs for new labs and higher debt interest pulled profit down by a third.

By Anant Kacholia, HexaWealth Research · Created 15 November 2026

Qualitek Labs' Q2 FY27 revenue jumped 33% year-on-year to ₹72 crore, but profit fell 30% sequentially to ₹7 crore. The squeeze came from higher staff costs, other expenses, and a doubling of interest outgo to fund rapid lab expansion.

For Qualitek Labs, the September quarter was a story of growth delivered at a rising cost. The testing services firm continued its rapid expansion, adding labs to capture a market driven by stricter quality regulations. Yet this quarter, the bill for that ambition arrived ahead of the full payoff.

Revenue reached ₹72 crore, up 33% from a year earlier and 3% from the March quarter. Profit, however, fell to ₹7 crore, a 30% sequential drop even as it rose 40% year-on-year. The net profit margin compressed by 460 basis points to 9.7%.

Revenue & profit

Revenue (₹ Cr.)

Profit (₹ Cr.)

Revenue & profitQ2 FY26 (Sep 2025) 54.0, Q4 FY26 (Mar 2026) 70.0, Q2 FY27 (Sep 2026) 72.0. Q2 FY26 (Sep 2025) 5.0, Q4 FY26 (Mar 2026) 10.0, Q2 FY27 (Sep 2026) 7.0020406080Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)Q2 FY27 (Sep 2026)
  • Revenue (₹ Cr.), Q2 FY26 (Sep 2025): 54.0
  • Revenue (₹ Cr.), Q4 FY26 (Mar 2026): 70.0
  • Revenue (₹ Cr.), Q2 FY27 (Sep 2026): 72.0
  • Profit (₹ Cr.), Q2 FY26 (Sep 2025): 5.0
  • Profit (₹ Cr.), Q4 FY26 (Mar 2026): 10.0
  • Profit (₹ Cr.), Q2 FY27 (Sep 2026): 7.0

Revenue (₹ Cr.)

Revenue (₹ Cr.)Q2 FY26 (Sep 2025) 54.0, Q4 FY26 (Mar 2026) 70.0, Q2 FY27 (Sep 2026) 72.0020406080Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)Q2 FY27 (Sep 2026)
  • Revenue (₹ Cr.), Q2 FY26 (Sep 2025): 54.0
  • Revenue (₹ Cr.), Q4 FY26 (Mar 2026): 70.0
  • Revenue (₹ Cr.), Q2 FY27 (Sep 2026): 72.0

Profit (₹ Cr.)

Profit (₹ Cr.)Q2 FY26 (Sep 2025) 5.0, Q4 FY26 (Mar 2026) 10.0, Q2 FY27 (Sep 2026) 7.005101520Q2 FY26 (Sep 2025)Q4 FY26 (Mar 2026)Q2 FY27 (Sep 2026)
  • Profit (₹ Cr.), Q2 FY26 (Sep 2025): 5.0
  • Profit (₹ Cr.), Q4 FY26 (Mar 2026): 10.0
  • Profit (₹ Cr.), Q2 FY27 (Sep 2026): 7.0

Net Profit Margin (%)

Net Profit Margin (%)Q2 FY26 (Sep 2025) 9.3, Q4 FY26 (Mar 2026) 14.3, Q2 FY27 (Sep 2026) 9.70%5%10%15%20%Q2 '26Q4 '26Q2 '27
  • Net Profit Margin (%), Q2 FY26 (Sep 2025): 9.3
  • Net Profit Margin (%), Q4 FY26 (Mar 2026): 14.3
  • Net Profit Margin (%), Q2 FY27 (Sep 2026): 9.7
MetricCurrentQ2 FY27 (Sep 2026)PreviousQ4 FY26 (Mar 2026)
Revenue (₹ Cr.)
72.0
70.0
Profit (₹ Cr.)
7.0
10.0
Net Profit Margin (%)
9.7
14.3

The expansion bill arrives

The profit squeeze came from costs rising faster than sales. According to reports from MCapital and Multibagg.ai, employee costs, other expenses, and finance charges all climbed sharply. Interest expense doubled year-on-year to ₹4 crore, a direct result of higher borrowings to fund capital work in progress (CWIP), which rose to nearly ₹70 crore.

This is the financial reality of a company in high-gear expansion. Qualitek added nine labs in the last 18 months, notes MCapital, which have a long-term revenue potential but currently incur losses during their gestation period. The company's debt-to-equity ratio stands at 0.72.

A long-term bet on regulation

The growth thesis remains intact, anchored in regulatory tailwinds. Stricter quality mandates from bodies like BIS and FSSAI are expanding the addressable market for testing, which Minerva Capital Research estimates at ₹30,000 crore for Qualitek. Management has guided for revenue to double every two years until reaching a ₹500 crore topline.

Live Chart

· QLL

(BSE)

ISIN: INE0Q1R01012

Recent wins, like a ₹10.2 crore order from Indian Oil Corporation reported by ScanX, show the demand pipeline. The focus now is on filling the newly built capacity, a process that typically takes two to three years for labs to reach breakeven.

Key Points

  • Revenue grew 33% year-on-year to ₹72 crore, but profit fell 30% quarter-on-quarter to ₹7 crore as costs outpaced sales.
  • The margin squeeze was driven by higher employee costs, other expenses, and a 100% year-on-year jump in interest expense to fund lab expansion.
  • The company's capital work in progress rose to ~₹70 crore, reflecting an aggressive expansion plan with a typical 2-3 year gestation for new labs to become profitable.
  • Long-term demand is underpinned by regulatory tightening, with management targeting a doubling of revenue every two years.

Hexa Perspective

The quarter lays bare the tension in Qualitek's model: high growth funded by debt, with profitability deferred until new capacity is utilized. The 460-basis-point sequential margin decline is a direct cost of that expansion.

For the thesis to hold, the company must successfully ramp up utilization in its new labs over the next several quarters to offset the rising interest and depreciation burden. Investors are betting that regulatory-driven demand will fill the capacity before leverage becomes a constraint. The next few quarters will test that timing.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Qualitek Labs (QLL) Q2 FY27 results, revenue and profits.

Frequently asked questions

What were Qualitek Labs' Q2 FY27 results?
Qualitek Labs reported Q2 FY27 revenue of ₹72 crore, a 33% year-on-year increase. Net profit was ₹7 crore, up 40% from the year-ago quarter but down 30% sequentially from the March 2026 quarter. The net profit margin for the quarter was 9.7%.
Why did Qualitek Labs' Q2 FY27 profit fall 30% QoQ?
Qualitek Labs' profit fell 30% quarter-on-quarter in Q2 FY27 despite a slight revenue increase because total expenses rose faster. Reports from MCapital and Multibagg.ai cite higher employee benefit costs, other operating expenses, and a significant rise in finance costs due to increased borrowing for lab expansion.
What was Qualitek Labs' net profit margin in Q2 FY27?
Qualitek Labs' net profit margin was 9.7% in Q2 FY27 (September 2026). This represents a decline of 460 basis points from the 14.3% margin in the previous quarter (Q4 FY26), pressured by rising operational and financing costs.
Why did Qualitek Labs' interest expense increase 100% YoY in Q2 FY27?
Qualitek Labs' interest expense doubled year-on-year in Q2 FY27 to ₹4 crore due to higher borrowings taken to fund its capital expansion. The company's capital work in progress rose significantly to finance the addition of new testing laboratories.
Is Qualitek Labs undertaking any capacity expansion?
Yes, Qualitek Labs is actively expanding its laboratory network. The company added 9 labs in the last 18 months and has a significant capital work in progress of nearly ₹70 crore as of September 2026, funded by a mix of debt and internal accruals, as per MCapital research.
What was Qualitek Labs management's guidance for FY27?
According to Minerva Capital Research, Qualitek Labs' management has guided for revenue to double every two years until it achieves a ₹500 crore topline, targeting EBITDA margins around 30% during this growth phase.
What is Qualitek Labs' current order backlog?
A specific backlog figure for Q2 FY27 is not disclosed, but the company recently won a significant ₹10.19 crore, three-year work order from Indian Oil Corporation for lab operations, as reported by ScanX, indicating a healthy demand pipeline.
What are the key risks facing Qualitek Labs?
Key risks include the long gestation period for new labs to break even, rising debt and interest costs funding expansion, and intense competition in the testing and certification sector from both multinationals and unorganized players, as noted in research reports.
Qualitek Labs Q2 profit drop
Qualitek Labs' Q2 FY27 (September 2026) net profit dropped 30% quarter-on-quarter to ₹7 crore. The decline was driven by a faster rise in expenses, including staff costs and a doubling of interest expense to ₹4 crore, which outpaced the modest 3% sequential revenue growth.
Qualitek Labs September quarter profit
Qualitek Labs reported a net profit of ₹7 crore for the September 2026 quarter (Q2 FY27). This was a 40% increase from the ₹5 crore profit in the same quarter last year, but a 30% decrease from the ₹10 crore profit in the immediate preceding quarter ended March 2026.